Literature DB >> 12590854

Otomycosis in Turkey: predisposing factors, aetiology and therapy.

K Murat Ozcan1, Muge Ozcan, Aydin Karaarslan, Filiz Karaarslan.   

Abstract

Otomycosis usually requires long-term treatment and tends to recur. This study was performed on 87 patients with the clinical diagnosis of otomycosis and 20 controls in order to determine the pathogenic agents, predisposing factors and a cost-effective treatment. The predisposing factors included wearing head clothes (74.7 per cent), presence of dermatomycoses (34.5 per cent) and swimming (27.6 per cent). The most common pathogenic fungus was Aspergillus niger (44.8 per cent) in the otomycosis group. The only isolate was Candida albicans in the control group (2.5 per cent). We concluded that administration of four per cent boric acid solution in alcohol and frequent suction cleaning of the ear canal might be a cost-effective treatment for otomycosis since 77 per cent of the patients were treated effectively this way. Eighty per cent of the resistant cases had mixed fungal-bacterial infections, and 50 per cent of them had dermatomycoses. These resistant cases were treated by administration of tioconazole ointment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590854     DOI: 10.1258/002221503321046621

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  24 in total

1.  Otomycoses of candidal origin in eastern Slovakia.

Authors:  E Dorko; A Jenca; M Orencák; S Virágová; E Pilipcinec
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

2.  Otomycosis due to filamentous fungi.

Authors:  Lidia García-Agudo; Pilar Aznar-Marín; Fátima Galán-Sánchez; Pedro García-Martos; Pilar Marín-Casanova; Manuel Rodríguez-Iglesias
Journal:  Mycopathologia       Date:  2011-04-17       Impact factor: 2.574

3.  Diabetes mellitus and candidiases.

Authors:  E Dorko; Z Baranová; A Jenca; P Kizek; E Pilipcinec; L Tkáciková
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

Review 4.  Otomycosis in iran: a review.

Authors:  Maral Gharaghani; Zahra Seifi; Ali Zarei Mahmoudabadi
Journal:  Mycopathologia       Date:  2015-01-30       Impact factor: 2.574

5.  Otomycosis in central iran: a clinical and mycological study.

Authors:  B Barati; S A R Okhovvat; A Goljanian; M R Omrani
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

6.  Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.

Authors:  Keyvan Kiakojuri; Saeid Mahdavi Omran; Somayeh Roodgari; Mojtaba Taghizadeh Armaki; Mohammad Taghi Hedayati; Tahereh Shokohi; Iman Haghani; Javad Javidnia; Firoozeh Kermani; Hamid Badali; Mahdi Abastabar
Journal:  Mycopathologia       Date:  2021-03-15       Impact factor: 2.574

7.  Otomycosis in Jos: Predisposing factors and Management.

Authors:  A S Adoga; A A Iduh
Journal:  Afr J Med Med Sci       Date:  2014-09

8.  Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.

Authors:  Gyöngyi Szigeti; Sándor Kocsubé; Ilona Dóczi; László Bereczki; Csaba Vágvölgyi; János Varga
Journal:  Mycopathologia       Date:  2012-02-23       Impact factor: 2.574

9.  Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents.

Authors:  Shadman Nemati; Rasool Hassanzadeh; Sina Khajeh Jahromi; Azimeh Delkhosh Nasrollah Abadi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-18       Impact factor: 2.503

10.  The ototoxic effect of boric acid solutions applied into the middle ear of guinea pigs.

Authors:  Sedat Oztürkcan; Riza Dündar; Hüseyin Katilmis; Ali Ekber Ilknur; Sinem Aktaş; Senem Haciömeroğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-16       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.